FDA Notices of Judgment Collection, 1908-1966
3921. Misbranding of methamphetamine hydrochloride tablets, pentobarbital sodium capsules, Tricombisul tablets, thyroid tablets, and Amytal Sodium ( capsules. U. S. v. Andrew J. Kennedy (Kennedy Drugs), and Paul J. Argust. Pleas of guilty. Fine of $400 against Defendant Kennedy and $200 against Defendant Argust.
- Case Number:
- 3921
- Collection:
- Drugs and Devices, 1940-1963
- Evidence Numbers:
- F. D. C. No. 33712. Sample Nos. 4 17021-L, 17048-L, 17325-L, 17563-L, 17567-L.
- Date Issued:
- August 1953
- Seizure Dates:
- May 4, 7, 9, and 11, 1951, and April 22, 1952
- Product Keywords:
- methamphetamine hydrochloride tablets, pentobarbital sodium capsules, Tricombisul tablets, thyroid tablets, and Amytal Sodium capsules
- Defendant Names:
- Andrew J. Kennedy, trading as Kennedy Drugs, Los Angeles, Calif., and Paul J. Argust, a pharmacist employed by Mr. Kennedy.
- Court Jurisdiction:
- Southern District of California
- Seizure Location:
- Los Angeles, Calif.
- Shipped From:
- Los Angeles, Calif.
- Shipped To:
- Los Angeles, Calif.
- Copyright:
- The National Library of Medicine believes this item to be in the public domain (More information)
